Karuna Therapeutics Other Current Liabilities

Karuna Therapeutics (KRTX) currently reports a other current liabilities of $17M as of December 2023. That compares with $29M in the prior-year period — down 42.3% year over year. Use the charts on this page to explore Karuna Therapeutics's other current liabilities history and peer comparisons.

Karuna Therapeutics's other current liabilities decreased from $29M to $17M — a 42.3% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Karuna Therapeutics reported $17M in other current liabilities as of December 2023. That compares with $29M in the prior-year period — down 42.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Karuna Therapeutics, and consider following KRTX for alerts when major investors trade the stock.

Karuna Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRTX with unrelated industries.